The Global Spinal Muscular Atrophy Medicine Market is projected to grow from USD 980.6 million in 2020 to USD 2,085.4 million by 2028 at a CAGR of over 13% during the forecast period 2022-2028. Spinal muscular atrophy (SMA) is a very rare genetic disorder that affects the part of the central nervous system that controls voluntary muscle movement. SMA is an autosomal recessive […]
